NCT06826170View on ClinicalTrials.gov

Hypofractionated Radiosurgery to Treat Residual/recurrent Non Secreting Pituitary Adenoma (HYPOADENO)

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

February 29, 2028

Study Completion Date

February 29, 2028

Conditions
Pituitary NeoplasmsPituitary Adenoma
Interventions
RADIATION

hypofractionated radiosurgery

The total dose will be 25 Gy, delivered in 5 fractions, in 5 consecutive days

Trial Locations (1)

20133

Fondazione IRCCS Istituto Neurologico C Besta, Milan

All Listed Sponsors
lead

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER